Crotoxin from Crotalus durissus terrificus is able to down-modulate the acute intestinal inflammation in mice

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  De Almeida, Caroline Souza ^a   Andrade Oliveira, Vinicius ^b   Câmara, Niels Olsen Saraiva ^b   Jacysyn, Jacqueline F ^b   Faquim Mauro, Eliana L ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CROTOXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOXIN A; MYELOPEROXIDASE; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; PEROXIDASE; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL POPULATION; COLITIS; CONTROLLED STUDY; CROTALUS; CROTALUS DURISSUS TERRIFICUS; CYTOKINE RELEASE; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOMODULATION; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; TH17 CELL; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; SECRETION (PROCESS);

ANIMALIA; CROTALUS DURISSUS TERRIFICUS; MURINAE; MUS;

ANIMALS; COLITIS; CROTALUS; CROTOXIN; FORKHEAD TRANSCRIPTION FACTORS; INFLAMMATION MEDIATORS; INTERLEUKIN-17; MALE; MICE; MICE, INBRED BALB C; PEROXIDASE; TH17 CELLS; TRINITROBENZENESULFONIC ACID;

EID: 84928914385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121427     Document Type: Article

References (97)

1. Geboes K. From inflammation to lesion. Acta Gastroenterol Belg. 1994; 57: 273-284. PMID: 7709695
2. Sartor RB Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am. 1995; 24: 475-507. PMID: 8809232
3. Kraus TA, Mayer L. Oral tolerance and inflammatory bowel disease. Curr Opin Gastroenterol. 2005; 21: 692-696. PMID: 16220047
4. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol. 1997; 92: 5S-11S. PMID: 9395346
5. Brandtzaeg P. Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses? Acta OdontolScand, 2001; 59: 235-243. PMID: 11570527
6. Shanahan F. Crohn's disease. Lancet. 2002; 359: 62-69. PMID: 11809204
7. Holtmann MH, Galle PR. Current concept of pathophysiological understanding and natural course of ulcerative colitis. Langenbecks Arch Surg. 2004; 89: 341-349.
8. Dignass AU, Baumgart DC, Sturm A. The etiopathogenesis of inflammatory bowel disease-immunology and repair mechanisms. Aliment Pharmacol Ther. 2004; 4: 9-17.
9. Kolios G, Petoumenos C, Nakos A. Mediators of inflammation: production and implication in inflammatory bowel disease. Hepatogastroenterology. 1998; 45: 1601-1609. PMID: 9840114
10. Holtmann MH, Galle PR, Neurath MF. Immunotherapeutic approaches to inflammatory bowel diseases. Expert Opin Biol Ther. 2001; 1: 455-466. PMID: 11727518
11. Walker JA, Barlow JL, McKenzie AN. Innate lymphoid cells-how did we miss them? Nat Rev Immunol. 2013; 13: 75-87. doi: 10.1038/nri3349 PMID: 23292121
12. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol. 2013; 13: 145-149. doi: 10.1038/nri3365 PMID: 23348417
13. Killig M, Glatzer T, Romagnani C. Recognition strategies of group 3 innate lymphoid cells. Front Immunol. 2014; 5: 2-8. doi: 10.3389/fimmu.2014.00002 PMID: 24478771
14. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II, et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med. 2009; 206: 35-41. doi: 10.1084/jem.20072713 PMID: 19114665
15. Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA, Artis D. CD4 (+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity. 2011; 34: 122-134. doi: 10.1016/j.immuni.2010.12.009 PMID: 21194981
16. Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, Hoyler T, et al. Regulated expression of nuclear receptor ROR gamma t confers distinct functional fates to NK cell receptor-expressing ROR gamma t (+) innate lymphocytes. Immunity. 2010; 33: 736-751. doi: 10.1016/j.immuni.2010.10.017 PMID: 21093318
17. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 2010; 464: 1371-1375. doi: 10.1038/ nature08949 PMID: 20393462
18. Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, Iuliano R, et al. Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol. 1999; 163: 143-147. PMID: 10384110
19. Pizarro TT, Michie MH, Bentz M, Woraratanadharm J, Smith MF Jr, Foley E, et al. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol. 1999 162: 6829-6835. PMID: 10352304
20. Dambacher J, Beigel F, Zitzmann K, De Toni EN, Göke B, Diepolder HM, et al. The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut. 2009; 58: 1207-1217. doi: 10.1136/gut.2007. 130112 PMID: 18483078
21. Maynard CL, Weaver CT. Intestinal effector T cells in health and disease. Immunity. 2009; 18: 389-400.
22. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001; 19: 683-765. PMID: 11244051
23. Grütz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol. 2005; 77: 3-15. PMID: 15522916
24. Doetze A, Satoguina J, Burchard G, Rau T, Löliger C, Fleischer B, et al. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int Immunol. 2000; 12: 623-630. PMID: 10784608
25. Harizi H1, Juzan M, Pitard V, Moreau JF, Gualde N. Cyclooxygenase-2-issued prostaglandin E (2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol. 2002; 168:2255-2263. PMID: 11859113
26. Harizi H, Norbert G. Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells. Cell Immunol. 2004; 228: 99-109. PMID: 15219461
27. Aliberti J, Hieny S, Reis e Sousa C, Serhan CN, Sher A. Lipoxin mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat Immunol; 2002; 3: 76-82. PMID: 11743584
28. Aliberti J, Serhan C, Sher A. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J Exp Med. 2002; 196: 1253-1262. PMID: 12417634
29. Parkinson JF. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation. Inflamm. Allergy Drug Targets. 2006; 5: 91-106. PMID: 16613568
30. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993; 75: 263-274. PMID: 8402911
31. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A. 1992; 89: 421-425. PMID: 1370356
32. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 2004; 265: 1237-1240.
33. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factorbeta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlow CD4+T cells. J Exp Med. 1996; 183: 2669-2674. PMID: 8676088
34. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev. 2005; 206: 260-276. PMID: 16048554
35. Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease J Pharmacol Toxicol Methods. (2004); 50: 81-92. PMID: 15385082
36. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002; 20: 495-549. PMID: 11861611
37. Slotta K, Franenkel-Conrat H. Estudos químicos sobre os venenos ofídicos. Purificação e cristalização do veneno da cobra cascavel. Mem Inst But. 1938; 12: 505-510.
38. Hawgood BJ, Smith JW. The mode of action at the mouse neuromuscular junction of the phospholipase A-crotapotin complex isolated from venom of the South American rattlesnake. Br J Pharmacol. 1977; 61: 597-606. PMID: 202359
39. Azevedo-Marques MM, Hering SE, Cupo P. Acidente crotálico. In: Cardoso JLC, França FOS, Wen FH, Málaque CMS, Hadda V Jr. Animais peçonhentos no Brasil: Biologia, clínica e terapêutica dos acidentes; 2003. pp. 91-107. doi: 10.1016/j.ttbdis.2014.03.010 PMID: 25271467
40. Bon C, Choumet V, Faure G, Jiang MS, Lambezat MP, Radvanyi F, et al. Biochemical analysis of the mechanism of action of crotoxin, a phospholipase A2 neurotoxin from snake venom. In: Dolly OJ, editors. Neurotoxins in Neurochemistry. Chichester: Ellis Horwood;1998. pp. 52-63.
41. Costa LA, Fornari MC, Berardi VE, Miles HA, Diez RA. In vivo effect of snake phospholipase A2 (crotoxin+ cardiotoxin) on serum IL-1alpha, TNF-alpha and IL-1ra level in humans. Immunol Lett. 2001; 75: 137-41. PMID: 11137138
42. Bolanos R, Cerdas L. The production and control of anti-venous sera. Developments in Biological Standardization. 1978; 41: 907-911.
43. Rolim-Rosa R, Vieira EGJ, Silles-Villarroel M, Siracusa YQ, Tizuka H. Análise comparativa entre os diferentes esquemas de hiperimunização empregados na produção de soros antiofídicos do Instituto Butantan. Mem Inst Butantan. 1980-1981; 44- 45: 259-265.
44. Schaeffer RC Jr, Randall H, Resk J, Carlson RW. Enzyme-linked immunosorbent assay (ELISA) of size-selected crotalid venom antigens by Wyeth's polyvalent antivenom. Toxicon. 1988; 26: 67-76. PMID: 3347932
45. Cardoso DF, Mota I. Effects of Crotalus venom on the humoral and cellular immune responses. Toxicon. 1997; 35: 607-612. PMID: 9133715
46. Rangel-Santos A, Lima C, Lopes-Ferreira M, Cardoso D. Immunosuppressive role of principal toxin (crotoxin) of Crotalus durissus terrificus venom. Toxicon. 2004; 44: 609-616. PMID: 15501286
47. Favoretto B, Ricardi R, Silva S, Jacysyn J, Fernandes I, Takehara H, Faquim-Mauro E. Immunomodulatory effects of crotoxin isolated from Crotalus durissus terrificus venom in mice immunized with human serum albumin. Toxicon.2011; 57: 600-607. doi: 10.1016/j.toxicon.2010.12.023 PMID: 21223974
48. Sampaio SC, Brigatte P, Sousa-e-Silva MC, dos-Santos EC, Rangel-Santos AC, Curi R, et al. Contribution of crotoxin for the inhibitory effect of Crotalus durissus terrificus snake venom on macrophage function. Toxicon. 2003; 41: 899-907. PMID: 12782091
49. Sampaio SC, Alba-Loureiro TC, Brigatte P, Landgraf RG, Dos Santos EC, Curi R, et al. Lipoxygenasederived eicosanoids are involved in the inhibitory effect of Crotalus durissus terrificus venom or crotoxin on rat macrophage phagocytosis. Toxicon. 200647: 313-321.
50. Nunes FP, Zychar BC, Della-Casa MS, Sampaio SC, Gonçalves LR, Cirillo MC. Crotoxin is responsible for the long-lasting anti-inflammatory effect of Crotalus durissus terrificus snake venom: involvement of formyl peptide receptors. Toxicon. 2010; 55: 1100-1106. doi: 10.1016/j.toxicon.2009.12.011 PMID: 20034508
51. Faure G, Choumet V, Bouchier C, Camoin L, Guillaume JL, Monegier B, et al. The origin of the diversity of crotoxin isoforms in the venom of Crotalus durissus terrificus. Eur J Biochem. 1994; 223: 161-164. PMID: 8033889
52. Bradford HF, Richards CD. Specific release of endogenous glutamate from piriform cortex stimulated in vitro. Brain Res. 1976; 105:168-172. PMID: 1252952
53. Fiorucci S, Antonelli E, Distrutti E, Del Soldato P, Flower RJ, Clark MJ, et al. NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Proc Natl Acad Sci U S A. 2002; 99: 15770-15775. PMID: 12427966
54. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis, 2006; 12: 382-38. PMID: 16670527
55. Alex P, Zachos N, Nguyen T, Gonzales B, Chen T, Conklin LS. et al. Distinct Cytokine Patterns Identified from Multiplex Profiles of DSS, Murine TNBS-induced Colitis. Inflam Bow Dis. 2009; 15: 341-352.
56. Bradley PP, Priebat DA, Christensen RD, Rothstein G.Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982; 78: 206-209. PMID: 6276474
57. Davies MD, Parrott DM. Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine. Gut. 1981; 22: 481-488. PMID: 6973508
58. Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhiCD4+ T cells. Immunity. 1994; 1: 553-562. PMID: 7600284
59. Monteleone I, Vavassori P, Biancone L, Monteleone G, Pallone F. Immunoregulation in the gut: success and failures in human disease. Gut. 2002; 50: 60-64.
60. Tsukada Y, Nakamura T, Iimura M, Iizuka BE, Hayashi N Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytopheresis. Am J Gastroenterol. 2002; 97: 2820-2828. PMID: 12425554
61. Pizarro TT, Cominelli F. Cytokine therapy for Crohn's disease: advances in translational research. Annu Rev Med. 2007; 58: 433-444. PMID: 17217333
62. Guan Q, Moreno S, Qing G,Weiss CR, Lu L, Bernstein CN, et al. The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis. J Leukoc Biol. 2013; 94: 803-811. doi: 10.1189/jlb.0113050 PMID: 23901119
63. Strober W, Fuss I, Mannon P.The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007; 117: 514-521. PMID: 17332878
64. Wirtz S1, Neufert C, Weigmann B, Neurath MF.Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007; 2: 541-546. PMID: 17406617
65. Castro FR, Farias AS, Proença PL, de La Hoz C, Langone F, Oliveira EC, et al. The effect of treatment with crotapotin on the evolution of experimental autoimmune neuritis induced in Lewis rats. Toxicon. 2007; 49: 299-305. PMID: 17145071
66. Garcia F, Toyama MH, Castro FR, Proença PL, Marangoni S, Santos LM. Crotapotin induced modification of T lymphocyte proliferative response through interference with PGE2 synthesis. Toxicon. 2003; 42: 433-437. PMID: 14505945
67. Sampaio SC, Rangel-Santos AC, Peres CM, Curi R, Cury Y. Inhibitory effect of phospholipase A(2) isolated from Crotalus durissus terrificus venom on macrophage function. Toxicon. 2005; 45: 671-676. PMID: 15777963
68. Zambelli VO, Sampaio SC, Sudo-Hayashi LS, Greco K, Britto LR, Alves AS, et al. Crotoxin alters lymphocyte distribution in rats: involvement of adhesion molecules and lipoxygenase-derived mediators. Toxicon. 2008; 51: 1357-1367. doi: 10.1016/j.toxicon.2008.03.004 PMID: 18452962
69. Sousa e Silva MCC, Gonçalves LRC, Mariano M. The venom of South American rattlesnake inhibits macrophage functions and is endowed with anti-inflammatory properties. Med Inflamm. 1996; 5: 18-23.
70. Cardoso DF, Lopes-Ferreira M, Faquim-Mauro EL, Macedo MS, Farsky SH. Role of crotoxin, a phospholipase A2 isolated from Crotalus durissus terrificus snake venom, on inflammatory and immune reactions. Mediators Inflamm. 2001; 10: 125-133. PMID: 11545249
71. Lima TS, Cataneo SC, Iritus AC, Sampaio SC, Della-Casa MS, Cirillo MC. Crotoxin, a rattlesnake toxin, induces a long-lasting inhibitory effect on phagocytosis by neutrophils. ExpBiol Med. 2002; 23: 1219-1230.
72. McAlindon ME, Hawkey CJ, Mahida YR. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut. 1998; 42: 214-219. PMID: 9536946
73. Yamada T, Zimmerman BJ, Specian RD, Grisham MB. Role of neutrophils in acetic acid-induced colitis in rats. Inflammation. 1991; 15: 399-411. PMID: 1757127
74. Natsui M, Kawasaki K, Takizawa H, Hayashi SI, Matsuda Y, Sugimura K, et al. Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats. J Gastroenterol Hepatol. 1997; 12: 801-808. PMID: 9504889
75. Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014; 5: 329-342. doi: 10. 1038/nri3661 PMID: 24751956
76. Begue B,Wajant H, Bambou JC, Dubuquoy L, Siegmund D, Beaulieu JF, et al. Implication of TNF-related apoptosis inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology. 2006; 130: 1962-1974. PMID: 16762619
77. Ford AC, Sandborn WJ, Khan KJ, Hanauer SB, Talley NJ, Moayyedi P. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am. J. Gastroenterol. 2011; 106:644-659. doi: 10.1038/ajg.2011.73 PMID: 21407183
78. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H. IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol. 2000; 164: 4878-4882. PMID: 10779797
79. Bai A, Lu N, Guo Y, Liu Z, Chen J, Peng Z. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J of Leukocyte Biology. 2009; 86: 959-969. doi: 10.1189/jlb.0109006 PMID: 19477911
80. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011; 474: 298-306 doi: 10.1038/nature10208 PMID: 21677746
81. Ermann J, Staton T, Glickman JN, de Waal Malefyt R, Glimcher LH. Nod/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-/-Rag2-/- (TRUC) mice. Proc Natl Acad Sci. 2014; 111: E2559-66. doi: 10.1073/pnas.1408540111 PMID: 24927559
82. Powell N, Walker AW, Stolarczyk E, Canavan JB, Gökmen MR, Marks E, et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity. 2012; 37: 674-684. doi: 10.1016/j.immuni.2012.09.008 PMID: 23063332
83. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.J Immunol. 1996; 157: 1261-1270. PMID: 8757634
84. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, et al. Type 1 t-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol. 1997; 150: 823-832. PMID: 9060820
85. Leppkes M, Becker C, Ivanov II, Hirth S, Wirtz S, Neufert C, et al. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.Gastroenterology. 2008; 136: 257-267. doi: 10.1053/j.gastro.2008.10.018 PMID: 18992745
86. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut, 2009; 58: 1152-1167. doi: 10.1136/gut.2008.163667 PMID: 19592695
87. Awane M, Andres PG, Li DJ, Reinecker HC. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol. 1999; 162: 5337-5344. PMID: 10228009
88. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, et al.Increased expression of interleukin17 in inflammatory bowel disease. Gut. 2003; 52: 65-70. PMID: 12477762
89. Jin Y, Lin Y, Lin L, Zheng C. IL-17/IFN-ã interactions regulate intestinal inflammation in TNBS-induced acute colitis. J Interferon Cytokine Res. 2012; 32: 548-556. doi: 10.1089/jir.2012.0030 PMID: 23030668
90. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010; 107: 12204-12209. doi: 10.1073/pnas. 0909122107 PMID: 20566854
91. Ogino H, Nakamura K, Ihara E, Akiho H, Takayanagi R.CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model. Dig Dis Sci. 2011; 56: 376-386. doi: 10.1007/s10620-010-1286-2 PMID: 20521112
92. Fuss I, Boirivant M, Lacy B. The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis. The Journal of Immunology. 2002; 168: 900-908. PMID: 11777988
93. Mahaseth M, Zhang Y. Hyaluronic acid as a rescue therapy for trinitrobenzene sulfonic acid-induced colitis through Cox-2 and PGE2 in a Toll-like receptor 4-dependent way. J Zhejiang Univ Sci. 2011; B12: 712-719. doi: 10.1631/jzus.B1000362 PMID: 21887846
94. Baratelli F, Lin Y, Zhu L, Yang SC, Heuzé-Vourc'h N, Zeng G, et al. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. JImmunol. 2005; 175: 1483-1490. PMID: 16034085
95. Chen H, Qin J, Wei P, Zhang J, Li Q, Fu L, et al. Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells. Prostaglandins Leukot Essent Fatty Acids. 2009; 80: 195-200. doi: 10.1016/j.plefa.2009.01.006 PMID: 19264469
96. Souza DG, Fagundes CT, Amaral FA, Cisalpino D, Sousa LP, Vieira AT, et al. The required role of endogenously produced lipoxinA4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. J Immunol. 2007; 179: 8533-8543. http://www.ncbi.nlm.nih.gov/pubmed/ ?term=SOUZA+2007+lipoxin PMID: 18056401
97. Silva NG, Sampaio SC, Gonçalves LR. Inhibitory effect of Crotalus durissus terrificus venom on chronic edema induced by injection of bacillus Calmette-Guérin into the footpad of mice Toxicon. 2013; 63: 98-103. doi: 10.1016/j.toxicon.2012.12.003 PMID: 23246578